CClinicalTrials.gg
Status unknownNCT00931424Updated Jul 2, 2009

The Clinical Trial for Primary Chronic Venous Insufficiency

An interventional study of valve reconstruction in Primary Chronic Venous Insufficiency, sponsored by Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 15 Years to 70 Years. Per ClinicalTrials.gov, last updated 2009-07-02.

Sponsored by Sun Yat-sen University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2009), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
15 Years to 70 Years
Sex
All
01

Study summary

A multicenter Random Clinical Trial to confirm the advantage of the valve reconstructive surgery on Primary Chronic Venous Insufficiency.

02

Conditions studied

  • Primary Chronic Venous Insufficiency

Browse trials for

Keywords

  • Primary Chronic Venous Insufficiency
  • surgery
  • reconstruction
  • valve
03

In context

Venous Insufficiency

189 studies on the registry are indexed under Venous Insufficiency; 16 are open to participants now.

This study's planned enrollment of 400 is above the median of 60 across 139 interventional studies indexed under Venous Insufficiency.

Browse Venous Insufficiency studies →

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • PCVI patients with III degree back flow in deep vein that is confirmed by color doppler or phlebography

Exclusion criteria

Exclusion Criteria:

  • age over 70 years old
  • pregnancy
  • patients with severity arteriosclerosis obliterans, malignancy, severity disease of heart, lung or brain, and hematopathy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    reconstruction

    patients in this group will have both valve reconstruction and superficial vein surgery

    Procedure: valve reconstruction

  • No intervention
    unreconstruction

    patients in this group will only have superficial vein surgery

Interventions

  • Procedurevalve reconstruction

    reconstruct valve at the same time of superficial vein surgery

06

What researchers measure

Primary outcomes

  1. clinical-etiology-anatomic-pathophysiologic classification system

    Time frame: 3 month, 1 year, 3 year, 5 year, 7 year

Secondary outcomes

  1. phlebography

    Time frame: 3 month, 1 year, 3 year, 5 year, 7 year

  2. color doppler

    Time frame: 3 month, 1 year, 3 year, 5 year, 7 year

07

Study locations

1 of 1 sites recruiting
  • The first affiliated hospital of Sun Yat-Sen University
    Guang Zhou, Guang dong 510080, China
    • Shen-ming Wang, Doctor · Contact · shenmingwang@sohu.com · +86 020 87755766-8198
    • Shen-ming Wang, professor · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00931424
Lead sponsor
Sun Yat-sen University
First posted
Jul 2, 2009
Start date
Jan 2006
Primary completion
Dec 2015 (estimated)
Last update
Jul 2, 2009

Study contacts

Shen-ming Wang, Professor
Contact
shenmingwang@sohu.com
+86 020 87755766-8198
Shen-ming Wang, doctor
study chair · First Affiliated Hospital, Sun Yat-Sen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion